Literature DB >> 8836887

Histopathologic findings in chronic hepatitis C.

H P Fischer1, E Willsch, E Bierhoff, U Pfeifer.   

Abstract

Evaluation of liver biopsies in hepatitis C is aimed at confirming the clinical and serologic diagnosis, grading of necroinflammatory activity, staging of consecutive fibrosis, ruling out or confirming liver diseases of different etiology, and assessment of therapeutic effects. Usually, the course of chronic hepatitis C virus (HCV) infection is slow, with mild inflammatory changes. Nevertheless, even in mild asymptomatic chronic hepatitis C episodes of higher inflammatory activity associated with extensive piecemeal necrosis and porto-central bridging, necrosis can accelerate the course of the disease. For this reason, the traditional, morphologically based classification of chronic hepatitis and the term "chronic persistent hepatitis" have lost their predictive usefulness, especially in hepatitis C. Chronic hepatitis should be characterized by etiologic designation as well as grade and stage of the disease. Portal lymphoid aggregates, some inflammatory bile duct damage and mild steatosis are the most characteristic features by which hepatitis C can be differentiated from other progressive inflammatory liver diseases. Antibodies directed against HCV antigens allow identification of viral proteins by immunohistochemistry. Immunostaining for hepatitis B antigens, for alpha-1-antitrypsin and copper staining are helpful in detecting hepatitis B and congenital liver diseases (Wilson's disease, alpha-1-antitrypsin deficiency) as possible causes of chronic progressive inflammatory liver disease. Centrilobular Mallory's hyalin, identified by immunostaining for ubiquitin in combination with perivenular fibrosis, is helpful in diagnosing concomitant alcoholic liver disease. In our own biopsy material (n = 100) and autopsy material (n = 58), HIV/HCV-coinfected patients have a significantly higher rate of fibrosis and cirrhosis than HIV patients without HCV infection. Hepatitis C can apparently aggravate the course of HIV infection. Our morphologic findings support the clinical observation that chronic HCV infection seems to be the main cause of liver failure, especially in the risk group of HCV/HIV-coinfected hemophiliacs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8836887

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  11 in total

1.  Increased levels of gammaGT suggest the presence of bile duct lesions in patients with chronic hepatitis C: absence of influence of HCV genotype, HCV-RNA serum levels, and HGV infection on this histological damage.

Authors:  E Giannini; F Botta; A Fasoli; P Romagnoli; L Mastracci; P Ceppa; I Comino; A Pasini; D Risso; R Testa
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

2.  Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection.

Authors:  E Bierhoff; H P Fischer; E Willsch; J Rockstroh; U Spengler; H H Brackmann; J Oldenburg
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

Review 3.  Histopathology and detection of hepatitis C virus in liver.

Authors:  P J Scheuer; K Krawczynski; A P Dhillon
Journal:  Springer Semin Immunopathol       Date:  1997

Review 4.  Leptin in the field of hepatic fibrosis: a pivotal or an incidental player?

Authors:  Sotirios K Bethanis; Stamatios E Theocharis
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

5.  Correlation of serum leptin levels with anthropometric and metabolic parameters and biochemical liver function in Chinese patients with chronic hepatitis C virus infection.

Authors:  Zheng-Wen Liu; Ni Zhang; Qun-Ying Han; Jun-Tao Zeng; Yong-Lie Chu; Jian-Ming Qiu; Ya-Wen Wang; Lie-Ting Ma; Xiao-Qin Wang
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

6.  In vivo, high-field, 3-Tesla 1H MR spectroscopic assessment of liver fibrosis in HCV-correlated chronic liver disease.

Authors:  A Orlacchio; F Bolacchi; M Angelico; A Mancini; V Cozzolino; M Cadioli; G Simonetti
Journal:  Radiol Med       Date:  2008-04-02       Impact factor: 3.469

7.  Hepatic steatosis in hepatitis C is a storage disease due to HCV interaction with microsomal triglyceride transfer protein (MTP).

Authors:  Silvia Mirandola; David Bowman; Mahmood M Hussain; Alfredo Alberti
Journal:  Nutr Metab (Lond)       Date:  2010-02-23       Impact factor: 4.169

Review 8.  [Liver biopsy at the intersection of clinical and pathological diagnosis].

Authors:  U Spengler; H-P Fischer
Journal:  Pathologe       Date:  2008-02       Impact factor: 1.011

9.  Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.

Authors:  L Castéra; C Hézode; F Roudot-Thoraval; A Bastie; E-S Zafrani; J-M Pawlotsky; D Dhumeaux
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

10.  Study of Chronic Hepatopathy in Patients With Sickle Cell Disease.

Authors:  Maha M Maher; Amany H Mansour
Journal:  Gastroenterology Res       Date:  2009-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.